Zymeworks and Leo Pharma enter licensing and research collaboration for bispecific antibodies Oct. 24, 2018
Phase I/II study of KB-103 meets all primary efficacy and safety endpoints at interim data analysis Oct. 16, 2018
Foamix reports further data from third phase III trial of FMX-101 for moderate to severe acne Oct. 2, 2018
RSS